Technology areas: Semiconductors, Circuits & Optics • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Glaiverf Inc. currently has 2 pending office actions in the Semiconductors, Circuits & Optics technology area. This level of activity suggests an ongoing effort to protect innovations in high-tech fields such as semiconductor design or optical systems. The 2 pending actions are the primary focus of the company's current patent prosecution strategy and resource allocation.
The examination of these applications is distributed across 2 distinct examiners and 2 distinct art units. This distribution requires the company to manage different sets of examiner expectations and art unit guidelines simultaneously. The 2 distinct art units indicate that the company's patent applications may cover different technical specialties within the broader semiconductor and optics field.
PINKNEY, DAWAYNE is the busiest examiner for the portfolio, with 1 busiest examiner pending action currently under review. This 1 pending action is one of the 2 pending office actions for the company. Monitoring the specific preferences and past decisions of this examiner is a critical component of the current prosecution strategy for the company.
With 2 distinct examiners involved, the company must ensure that its legal and technical arguments remain consistent across both cases. The 2 pending office actions in the Semiconductors, Circuits & Optics area represent the current boundary of the company's active intellectual property development and its efforts to secure technological leads.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PINKNEY, DAWAYNE | 1 | 80.6% | +18.0% |
| NIA, ALIREZA | 1 | 41.7% | +49.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18384585 | Switched Light Source Microlens Array (SLSMA) for Retina Projection | PINKNEY, DAWAYNE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18134589 | ENDOSCOPIC COHERENT TISSUE ABLATION | NIA, ALIREZA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18384585 | Switched Light Source Microlens Array (SLSMA) for Retina Projection | PINKNEY, DAWAYNE | — |
| 18134589 | ENDOSCOPIC COHERENT TISSUE ABLATION | NIA, ALIREZA | — |
| Art Unit | Apps |
|---|---|
| 2872 | 1 |
| 3786 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18384585 | Switched Light Source Microlens Array (SLSMA) for Retina Projection | PINKNEY, DAWAYNE | 2872 | §103 | Non-Final OA | — | Pending | Oct 27, 2023 |
| 18134589 | ENDOSCOPIC COHERENT TISSUE ABLATION | NIA, ALIREZA | 3786 | §103§112 | Final Rejection | — | Pending | Apr 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGlaiverf Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Dawayne Pinkney has the most, with 1 of Glaiverf Inc.'s pending office actions.
Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.
